PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 20260 citationsOpen Access

Techniques for Bioavailability Enhancement of BCS Class Ii Drugs: A Review

View Full Paper
*W*Sakshi Khot, Samiksha Dadas, Om Pandekar, Ravi Barkade, Dr. G. H. Wadkar

Key Points

  • The review aims to summarize methods for improving the solubility of BCS Class II drugs, which are often poorly soluble yet highly permeable.
  • Reviewed traditional and contemporary techniques for solubility enhancement
  • Highlighted solid dispersions and complexation with cyclodextrins
  • Discussed nanosizing and surfactant formulations
  • Examined recent innovations like amorphous formulations and supercritical fluid technology
  • Identified various techniques with pros and cons for improving drug effectiveness
  • Noted that solid dispersions and cyclodextrin complexation were effective enhancement methods
  • Highlighted the significance of lipid-based formulations in increasing bioavailability

Abstract

Drugs have different degrees of solubility which has an impact on the bioavailability of the drug in the body. Low solubility drugs in water have the greatest solubility problems. The effectiveness of drug formulations and therapies is limited for Class II BCS drugs, which exhibit high permeability but poor solubility. This review focuses on various techniques Employed to improve the solubility of BCS Class II drugs. A number of traditional and contemporary methods are employed. These include solid dispersions, complexation with cyclodextrins, nanosizing, surfactant formulations, and lipid-based drugs. The review covers in detail the mechanism of molecular dispersion, complexation with cyclodextrins, nano-crystallization, surfactant formulations, and lipid-based drugs, discussing the pros and cons of each method. The review also covers the recent innovations in the formulation BCS Class II like amorphous drug formulations, supercritical fluid technology, and nanocrystals.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

*Sakshi Khot, Samiksha Dadas, Om Pandekar, Ravi Barkade, Dr. G. H. Wadkar (2026) studied this question.

synapsesocial.com/papers/69a3d843ec16d51705d2ef1fhttps://doi.org/10.5281/zenodo.18803406
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Methods of Enhancing the Solubility and Bioavailability of BCS Classification II Drugs2026 · 1 citations
  2. 2Strategic Advances in Drug Delivery Systems for Overcoming Solubility and Permeability Barriers in Class II and IV Drugs2026
  3. 3Advanced Techniques in Solubility Enhancement of Poorly Water-Soluble Drugs2025
  4. 4Enhancing the Solubility of BCS Class IV Antibiotics to Unleash Their Potential2026
  5. 5ENHANCEMENT OF ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS USING NANOSUSPENSION TECHNOLOGY: A COMPREHENSIVE STUDY2026